date:Apr 18, 2014
the timeliness and synchronization of U.S. and foreign governmental approvals of biotechnology-enhanced traits.
But, the N.G.F.A. said its economic analyses of the impacts of the trade disruptions resulting from the detection of unapproved Agrisure Viptera MIR 162 provides a case study on the ramifications of commercializing crop biotechnology before securing import approvals from major U.S. export markets particularly foreign countries with a zero-tolerance policy for the presence of unappro